Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Vaccines

Free Subscription 11.05.2026 1 BMJ 2 Clin Infect Dis 1 Indian Pediatr 1 J Infect 1 J Pediatr 1 J Virol 2 Lancet 1 N Engl J Med 1 Pediatr Infect Dis J 2 Pediatrics 4 PLoS One 2 Science 19 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMJ

1. DOYON-PLOURDE P, Chong J, Abrams EM, Pless R, et al
   Aluminium adjuvants in vaccines and potential health effects: systematic review.
   BMJ. 2026;393:e088921.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

2. BOZIO CH, Patel M, Reed C, Garg S, et al
   Challenges in defining severe influenza with implications for measuring and communicating influenza vaccine effects.
   Clin Infect Dis. 2026 May 7:ciag304. doi: 10.1093.
   PubMed         Abstract available
   
   
3. TOWER BM, Liu CM, Diemert DJ, Nelson SG, et al
   Influenza A and B Viral Shedding in Adults Immunized with Live Attenuated Influenza Vaccine.
   Clin Infect Dis. 2026 May 7:ciag294. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Indian Pediatr

4. KOMPITHRA RZ, Varghese R, Muruganantham G, Mathew G, et al
   From 10-Valent to 21-Valent Pneumococcal Conjugate Vaccines: Divergent Global Pathways and Future Directions for India.
   Indian Pediatr. 2026 May 4. doi: 10.1007/s13312-026-00331.
   PubMed         Abstract available
   
   

   
   J Infect

5. YAMBA YAMBA L, Udden F, Dalence S, de Bruijn A, et al
   Pneumococcal serotype epidemiology and resistance after PCV13 replacement with PCV10, Sweden.
   J Infect. 2026;92:106723.
   PubMed         Abstract available
   
   

   
   J Pediatr

6. CRISTOFORI F, Castellaneta S, Dargenio VN, Francavilla R, et al
   Nationwide Evidence on Rotavirus Vaccination and Celiac Disease: Strengths and Remaining Gaps.
   J Pediatr. 2026 Apr 29:115134. doi: 10.1016/j.jpeds.2026.115134.
   PubMed        
   
   

   
   J Virol

7. JIANG S, Cui J, Sun T, Li J, et al
   A chimeric trivalent Echovirus vaccine designed by loop substitution elicits cross-neutralizing immunity against serotypes 11, 18, and 30.
   J Virol. 2026 May 5:e0045726. doi: 10.1128/jvi.00457.
   PubMed         Abstract available
   
   

   
   Lancet

8. CLIFFORD GM
   HPV vaccine scale-up is key to curb rising cervical cancer inequalities.
   Lancet. 2026;407:1662-1663.
   PubMed        
   
   
9. BRISSON M, Drolet M, Gingras G, Laprise JF, et al
   Substantial increases in cervical cancer inequalities worldwide without enhanced human papillomavirus vaccination and screening efforts: a global modelling study.
   Lancet. 2026;407:1726-1737.
   PubMed         Abstract available
   
   

   
   N Engl J Med

10. LEROUX-ROELS I, Huang G, Ferguson M, Kohli A, et al
    Efficacy and Safety of an mRNA Seasonal Influenza Vaccine in Adults.
    N Engl J Med. 2026;394:1803-1813.
    PubMed         Abstract available
    
    

    
    Pediatr Infect Dis J

11. PLOTKIN SA
    Why Is Mumps Vaccine not Persistently Effective?
    Pediatr Infect Dis J. 2026 May 8. doi: 10.1097/INF.0000000000005244.
    PubMed        
    
    

    
    Pediatrics

12. RAJNIK M, Ottolini M
    Reducing the Impact of RSV in Infants: Vaccinate Mothers, Passively Immunize Newborns, or Both?
    Pediatrics. 2026 May 4:e2025075676. doi: 10.1542/peds.2025-075676.
    PubMed        
    
    
13. ROSTAD CA, Healy CM, Nayak JL, Parameswaran L, et al
    Maternal RSV Vaccination, Infant Nirsevimab, or Both: Interim Analysis of a Randomized Trial.
    Pediatrics. 2026 May 4:e2025075223. doi: 10.1542/peds.2025-075223.
    PubMed         Abstract available
    
    

    
    PLoS One

14. DO NASCIMENTO AI, Dos Santos Conrado D, Mareto LK, de Azevedo MV, et al
    Age and vaccine information sources drive vaccine hesitancy: A household survey in Central-Western Brazil.
    PLoS One. 2026;21:e0348412.
    PubMed         Abstract available
    
    
15. SEIFI N, Nezafat N, Hajizade MS, Negahdaripour M, et al
    Design and in silico evaluation of an mRNA vaccine against HTLV-1 using AI-driven reverse vaccinology approaches.
    PLoS One. 2026;21:e0340201.
    PubMed         Abstract available
    
    
16. ESSAYAGH T, Essayagh M, Nmila K, Slibani H, et al
    Prevalence and determinants of parental refusal of human papillomavirus vaccination in Morocco: A multicenter cross-sectional study.
    PLoS One. 2026;21:e0348586.
    PubMed         Abstract available
    
    
17. HE Q, Zou X, Zheng C, Zhang J, et al
    Identification and functional analysis of key miRNAs and target genes associated with failure of HBV mother-to-child transmission prevention.
    PLoS One. 2026;21:e0348899.
    PubMed         Abstract available
    
    

    
    Science

18. COHEN J
    After pulling vaccine study, CDC leader calls for new journal.
    Science. 2026;392:564-565.
    PubMed         Abstract available
    
    
19. SKELLY AN, Gristick HB, Li H, Gavor E, et al
    Induction of broadly neutralizing HIV antibodies by a two-step mechanism informs vaccine design.
    Science. 2026 May 7:eaec6396. doi: 10.1126/science.aec6396.
    PubMed         Abstract available
    
    

    
    Vaccine

20. DHURI K, Ubhe A
    Emerging lipids-based adjuvant delivery technologies for vaccines.
    Vaccine. 2026;84:128662.
    PubMed         Abstract available
    
    
21. ISAH A, Ugochukwu EJ, Mbachu CO, Agu IC, et al
    Leaving no child behind? developing zero-dose and under-immunized child archetypes to improve vaccine uptake in Nigeria.
    Vaccine. 2026;84:128678.
    PubMed         Abstract available
    
    
22. REYNALDI A, Lee WS, Selva KJ, Audsley J, et al
    Immune responses associated with protection from SARS-CoV-2 infection.
    Vaccine. 2026;81:128579.
    PubMed         Abstract available
    
    
23. KONLAN M, Bhandari R, Owusu SA, Kubio C, et al
    The effect of the COVID-19 pandemic on routine childhood immunization coverage and dropout: A community-based cross-sectional study in the Tamale Metropolis, Ghana.
    Vaccine. 2026;81:128584.
    PubMed         Abstract available
    
    
24. RICE E, Cheng AC, Britton PN, Carr J, et al
    Influenza epidemiology, treatment and prevention in Australian children: Trends from 6 years of PAEDS-FluCAN influenza surveillance (2019-2024).
    Vaccine. 2026;82:128592.
    PubMed         Abstract available
    
    
25. KHODR ZG, Hall C, Bukowinski AT, Gumbs GR, et al
    Comparison of Tdap vaccine immunogenicity between pregnant and non-pregnant active duty service members.
    Vaccine. 2026;83:128627.
    PubMed         Abstract available
    
    
26. YOON D, Lee H, Lee Y, Chun J, et al
    Recombinant AcHERV-baculovirus vaccine elicits robust immune responses against human norovirus.
    Vaccine. 2026;83:128641.
    PubMed         Abstract available
    
    
27. TURNER N, Castelino L, Paynter J, Willing E, et al
    Tailoring the Australian vaccine barriers assessment tool (VBAT) for Aotearoa New Zealand: Using a local equity approach.
    Vaccine. 2026;83:128636.
    PubMed         Abstract available
    
    
28. SHI J, Wang J, Luo H, Zhao Q, et al
    Neoantigen-based T cell vaccines design strategies, therapeutic barriers, and clinical advances.
    Vaccine. 2026;83:128659.
    PubMed         Abstract available
    
    
29. UKAH UV, Haapala JL, Benitez GV, DeSilva MB, et al
    Language and racial disparities in COVID-19 vaccination during pregnancy and lactation.
    Vaccine. 2026;83:128638.
    PubMed         Abstract available
    
    
30. FORTIN E, Miron E, Grewal R, Wilson SE, et al
    Does an off-label two-dose RotaTeq vaccine schedule translate into a higher incidence of rotavirus hospital admissions compared to the approved three-dose RotaTeq schedule? A Canadian immunization research network study.
    Vaccine. 2026;83:128628.
    PubMed         Abstract available
    
    
31. PAUL KK, Torres M, Shih STF, Gray RT, et al
    Respiratory syncytial virus (RSV) vaccination program for older Australians reduces health inequalities: a distributional cost-effectiveness analysis.
    Vaccine. 2026;83:128644.
    PubMed         Abstract available
    
    
32. MOUSA AAB, Thneibat FM, Al-Hamdan Z, Al-Hawarat MN, et al
    Cost-effectiveness of human papillomavirus vaccination in Jordan: A modelling study.
    Vaccine. 2026;83:128640.
    PubMed         Abstract available
    
    
33. PETER AM, Ambu SP, Davamani FA, Somanath SD, et al
    Corrigendum to "Heterologous DNA prime-crude tachyzoite lysate antigen boost targeting MIC8 confers protection against acute and chronic Toxoplasma gondii infection in mice" [Vaccine 80 (2026) 128554].
    Vaccine. 2026;83:128637.
    PubMed        
    
    
34. TUITE AR, Forbes N, Salvadori MI, Tunis M, et al
    Cost-effectiveness of ongoing COVID-19 vaccination in the context of high population immunity: A structured review of international economic evidence.
    Vaccine. 2026;83:128660.
    PubMed         Abstract available
    
    
35. KHAN IA, Dos Santos EC, Novaes RD, Carvalho RPR, et al
    Can a DNA vaccine protect against Chagas disease? A systematic review of preclinical studies.
    Vaccine. 2026;83:128654.
    PubMed         Abstract available
    
    
36. AHMAD A, Yousaf Z, Naeem M, Yasin M, et al
    Preparation and comparative evaluation of conjugate and whole-cell killed vaccine candidates against Salmonella enterica serovar Typhimurium.
    Vaccine. 2026;83:128601.
    PubMed         Abstract available
    
    
37. KRESS M, Heindl-Wruss J, Schlegl R, Jungbauer A, et al
    The impact of unspecific viral adsorption on pharmaceutical container surfaces in vaccine process development.
    Vaccine. 2026;84:128635.
    PubMed         Abstract available
    
    
38. MULLER MP, Soe P, Shulha HP, Isenor JE, et al
    mRNA COVID-19 vaccine safety in adults from the Canadian national vaccine safety network.
    Vaccine. 2026;84:128630.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum